Bionovate Technologies Corp.
company.status.inactiveCIK 1575420fmd_0VHZ7MNT43WEFSQM84KXJR48PPManufacturing · Electric Lighting & Wiring EquipmentTemplate: Standard
Coverage: Jul 01, 2011 to Sep 30, 2021, 38 periods
Latest annual · FY2021
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q1 FY2022
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
- Revenue, 5 yearsFY2016 to FY2021
- n/m
- Net income, 5 yearsFY2016 to FY2021
- n/m
Bionovate Technologies Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2021-10-14 · proof | |
| Operating income | -$45,371 | -$33,055 | 10-K 2021-10-14 · proof | |
| Net income | -$106,544 | -$122,045 | 10-K 2021-10-14 · proof | |
| Cash from operating activities | $0 | $0 | 10-K 2021-10-14 · proof | |
| Total assets | $0 | $0 | 10-K 2021-10-14 · proof | |
| Total liabilities | $503,209 | $396,665 | +26.9% | 10-K 2021-10-14 · proof |
| Cash and cash equivalents | $0 | $0 | 10-K 2021-10-14 · proof |
- What was Bionovate Technologies Corp.'s revenue in fiscal 2021?
- Bionovate Technologies Corp. reported revenue of $0 for fiscal 2021 (the year ended Jun 30, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What was Bionovate Technologies Corp.'s operating income in fiscal 2021?
- Bionovate Technologies Corp. reported operating income of -$45,371 for fiscal 2021 (the year ended Jun 30, 2021), against -$33,055 the year before. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What was Bionovate Technologies Corp.'s net income in fiscal 2021?
- Bionovate Technologies Corp. reported net income of -$106,544 for fiscal 2021 (the year ended Jun 30, 2021), against -$122,045 the year before. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What was Bionovate Technologies Corp.'s cash from operating activities in fiscal 2021?
- Bionovate Technologies Corp. reported cash from operating activities of $0 for fiscal 2021 (the year ended Jun 30, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What are Bionovate Technologies Corp.'s total assets?
- As of Jun 30, 2021, Bionovate Technologies Corp. reported total assets of $0, against $0 a year earlier. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What are Bionovate Technologies Corp.'s total liabilities?
- As of Jun 30, 2021, Bionovate Technologies Corp. reported total liabilities of $503,209, against $396,665 a year earlier (+26.9%). Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
- What are Bionovate Technologies Corp.'s cash and cash equivalents?
- As of Jun 30, 2021, Bionovate Technologies Corp. reported cash and cash equivalents of $0, against $0 a year earlier. Source: the 10-K filed with the SEC on Oct 14, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1575420&period_type=annual&limit=5"Information only, not investment advice.